CAPD and transplantation in diabetics

Area of Science:

• Nephrology
• Diabetology
• Internal Medicine

Background:

• Diabetic end-stage renal failure presents significant treatment challenges.
• Continuous Ambulatory Peritoneal Dialysis (CAPD) is an option for these patients.
• Long-term outcomes of CAPD in diabetic ESRD patients require evaluation.

Purpose of the Study:

• To assess the safety and efficacy of CAPD in insulin-dependent diabetic patients with end-stage renal failure.
• To evaluate clinical and biological parameters, including transplantation outcomes.
• To determine the suitability of CAPD for diabetic patients awaiting or ineligible for transplantation.

Main Methods:

• Retrospective analysis of 33 insulin-dependent diabetic patients undergoing CAPD for up to 70 months.
• Monitoring of clinical parameters (hypertension, hemoglobin, HbA1c) and biological markers (serum protein, phosphate, calcium).
• Assessment of peritonitis rates and patient survival rates; evaluation of post-transplantation outcomes in 7 patients.

Main Results:

• Acceptable levels of serum protein, phosphate, and calcium were maintained.
• Improved hemoglobin levels, hypertension control, and reduced medication requirements were observed.
• Near-normal HbA1c levels were achieved with subcutaneous insulin; peritonitis rate was 1/18 patient-months; survival rates were 83% (1st year) and 62% (2nd year).
• No CAPD-related complications occurred in 7 transplanted patients; 6 had successful graft function.

Conclusions:

• CAPD demonstrates good control of hypertension, blood glucose, and anemia in diabetic ESRD patients.
• The method avoids fluctuating fluid volumes, making it suitable for this population.
• CAPD is considered an optimal treatment for diabetic patients awaiting transplantation or those unsuitable for it.